Stockreport

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - 2024 net product sales of $336.4 million- 2025 expected global net product sales of $420 million to $435 million- VISTAS study of volixibat in PSC expected to complete [Read more]